Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $24.1900 (3.73%) ($23.5200 - $24.5000) on Tue. Jun. 4, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.34% (three month average) | RSI | 45 | Latest Price | $24.1900(3.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.6% a day on average for past five trading days. | Weekly Trend | ATRA declines -2.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(49%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.17% in a week (0% probabilities). VXX(-34%) TLT(-13%) UNG(-6%) IFRA(-5%) UUP(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.17% (StdDev 4.34%) | Hourly BBV | 0 () | Intraday Trend | 1% | | | |
|
1 - 5 Day Possible Target | $-0.9(-103.72%) | Resistance Level | $24.8 | 5 Day Moving Average | $23.16(4.45%) | 10 Day Moving Average | $23.23(4.13%) | 20 Day Moving Average | $24.8(-2.46%) | To recent high | -41.1% | To recent low | 8.9% | Market Cap | $1.798b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |